Our experiments reported here are part of the examination of a larger series of fusion proteins targeting truncated tissue factor (tTF) to the tumor vasculature by small NGR-peptides at the C-terminus of tTF with the result of tumor vessel thrombotic occlusion, infarction, and human tumor xenograft growth inhibition [13–18]. The gene discussed is RHOH; the disease is neoplasm.